Search results
Results from the WOW.Com Content Network
Vaping-associated pulmonary injury (VAPI), [4] also known as vaping-associated lung injury (VALI) [1] or e-cigarette, or vaping, product use associated lung injury (E/VALI), [2] [a] is an umbrella term, [15] [16] used to describe lung diseases associated with the use of vaping products that can be severe and life-threatening. [3]
Vaping may harm neurons and trigger tremors and spasms. [86] The use of e-cigarettes has been found associated with nose bleeding, change in bronchial gene expression, release of cytokines and proinflammatory mediators, and increase in allergic airway inflammation which can exacerbate asthmatic symptoms, thus elevating infiltration of ...
The company also stated that some news agencies report that several cases of lung illness are associated with vaping THC, found in cannabis, "a Schedule 1 controlled substance that we do not sell." [89] However recent research using commercially sourced JUUL nicotine vape products has documented harms from these devices.
Where marijuana may harm. Mental health: When it comes to easing the symptoms of anxiety, depression and other mental disorders, the analysis found no benefit. In fact, the opposite is actually ...
Scientists aren’t sure if cannabis use leads to anxiety, or if anxiety symptoms in many cannabis users are pre-existing but underdiagnosed, prompting users’ attempt to self-medicate.
Vaping cannabis has led to permanent lung damage in some users Another rare side effect of cannabis involves a particular method of ingesting it, vaping, rather than the substance itself.
Cannabis use disorder is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders as a condition requiring treatment. [107] Several drugs have been investigated in an attempt to ameliorate the symptoms of stopping cannabis use. Such drugs include bupropion, divalproex, nefazodone, lofexidine, and dronabinol.
People sometimes use cannabis to cope with their anxiety, and cannabis withdrawal can lead to symptoms of anxiety. [58] Buspirone, a serotonin 5-HT 1A receptor partial agonist, has shown limited efficacy for treating anxiety in people with cannabis use disorder, though there may be better efficacy in males than in females. [58]